These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28898877)

  • 1. Identification of Small and Non-Small Cell Lung Cancer Markers in Peripheral Blood Using Cytokinesis-Blocked Micronucleus and Spectral Karyotyping Assays.
    El-Zein RA; Abdel-Rahman S; Santee KJ; Yu R; Shete S
    Cytogenet Genome Res; 2017; 152(3):122-131. PubMed ID: 28898877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk.
    El-Zein RA; Schabath MB; Etzel CJ; Lopez MS; Franklin JD; Spitz MR
    Cancer Res; 2006 Jun; 66(12):6449-56. PubMed ID: 16778224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokinesis-blocked micronucleus cytome assay and spectral karyotyping as methods for identifying chromosome damage in a lung cancer case-control population.
    Lloyd SM; Lopez M; El-Zein R
    Genes Chromosomes Cancer; 2013 Jul; 52(7):694-707. PubMed ID: 23630028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model.
    El-Zein RA; Lopez MS; D'Amelio AM; Liu M; Munden RF; Christiani D; Su L; Tejera-Alveraz P; Zhai R; Spitz MR; Etzel CJ
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2462-70. PubMed ID: 25172871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers.
    El-Zein RA; Fenech M; Lopez MS; Spitz MR; Etzel CJ
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1111-9. PubMed ID: 18483333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
    Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
    Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the cytokinesis-blocked micronucleus assay to detect gender differences and genetic instability in a lung cancer case-control study.
    McHugh MK; Lopez MS; Ho CH; Spitz MR; Etzel CJ; El-Zein RA
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):135-45. PubMed ID: 23195992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaption of the Cytokinesis-Block Micronucleus Cytome Assay for Improved Triage Biodosimetry.
    Beinke C; Port M; Riecke A; Ruf CG; Abend M
    Radiat Res; 2016 May; 185(5):461-72. PubMed ID: 27092766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the genotoxicity and cytotoxicity in the general population in Turkey by use of the cytokinesis-block micronucleus cytome assay.
    Donmez-Altuntas H; Bitgen N
    Mutat Res; 2012 Oct; 748(1-2):1-7. PubMed ID: 22698568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokinesis-block micronucleus cytome assays for the determination of genotoxicity and cytotoxicity of cecal water in rats and fecal water in humans.
    Benassi B; Leleu R; Bird T; Clifton P; Fenech M
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2676-80. PubMed ID: 18086773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokinesis-Block Micronucleus Cytome Assay Evolution into a More Comprehensive Method to Measure Chromosomal Instability.
    Fenech M
    Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33076531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokinesis Block Micronucleus Cytome (CBMN Cyt) Assay Biomarkers and Their Association With Radiation Sensitivity Phenotype in Prostate Cancer Cases and DNA Repair Gene hOGG1 (C1245G) Polymorphism.
    Dhillon VS; Yeoh E; Salisbury C; Butters J; Di Matteo A; Olver I; Fenech M
    Environ Mol Mutagen; 2018 Dec; 59(9):813-821. PubMed ID: 30264500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for complete automated scoring of the cytokinesis block micronucleus cytome assay using imaging flow cytometry.
    Rodrigues MA; Beaton-Green LA; Wilkins RC; Fenech MF
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt A):53-64. PubMed ID: 30389163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear anomalies, chromosomal aberrations and proliferation rates in cultured lymphocytes of head and neck cancer patients.
    George A; Dey R; Bhuria V; Banerjee S; Ethirajan S; Siluvaimuthu A; Saraswathy R
    Asian Pac J Cancer Prev; 2014; 15(3):1119-23. PubMed ID: 24606428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death.
    Fenech M
    Mutat Res; 2006 Aug; 600(1-2):58-66. PubMed ID: 16822529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the genotoxicity and cytotoxicity in environmentally exposed human populations to heavy metals using the cytokinesis-block micronucleus cytome assay.
    Mesic A; Nefic H
    Environ Toxicol; 2015 Nov; 30(11):1331-42. PubMed ID: 24861359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the cut-off value of pro-gastrin releasing peptide (ProGRP) in lung cancer according to population characteristics.
    Bubanović G; Pavićević R; Franjević A
    Coll Antropol; 2008 Dec; 32(4):1155-64. PubMed ID: 19149223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal DNA damage measured using the cytokinesis-block micronucleus cytome assay is significantly associated with cognitive impairment in South Australians.
    Lee SL; Thomas P; Hecker J; Faunt J; Fenech M
    Environ Mol Mutagen; 2015 Jan; 56(1):32-40. PubMed ID: 25099033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular amyloid beta 42 causes necrosis, inhibition of nuclear division, and mitotic disruption under both folate deficient and folate replete conditions as measured by the cytokinesis-block micronucleus cytome assay.
    Lee SL; Thomas P; Fenech M
    Environ Mol Mutagen; 2014 Jan; 55(1):1-14. PubMed ID: 24038346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
    Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
    Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.